{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:10:09Z","timestamp":1772122209192,"version":"3.50.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["G17.1102"],"award-info":[{"award-number":["G17.1102"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>This retrospective cohort study was conducted to determine the prevalence of HCV infections among individuals incarcerated in a state prison system and identify potential contributing factors to HCV infection. North Dakota Department of Corrections and Rehabilitation (NDDOCR) data from 2009 to 2018 was used and period prevalence was calculated for this 10-year time period. The period prevalence of HCV infection was (15.13% (95% CI 14.39\u201315.90) with a marginally significant (p-value: 0.0542) increasing linear trend in annual prevalence over this period. Multivariate logistic regression analysis was used to identify risk factors associated with HCV infection. The main significant independent risk factors for HCV infection in this incarcerated population were age &gt;40 years [OR: 1.78 (1.37\u20132.32)]; sex [OR: 1.21 (1.03\u20131.43)]; race\/ethnicity [OR: 1.97 (1.69\u20132.29)]; history of intravenous drug use (IVDU) [OR: 7.36 (6.41\u20138.44)]; history of needle or syringe sharing [OR: 7.57 (6.62\u20138.67)]; and alcohol use [OR: 0.87 (0.77\u20130.99)]. Study limitations include uncollected information on sexual history, frequency or duration of injection drug use and blood transfusion history of the incarcerated population. Considering the high prevalence of HCV infection and its associated risk factors, it is important to implement prevention programs such as syringe\/needle exchanges and counsel with imprisoned IVD users.<\/jats:p>","DOI":"10.1371\/journal.pone.0266047","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:38:44Z","timestamp":1648575524000},"page":"e0266047","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota"],"prefix":"10.1371","volume":"17","author":[{"given":"Liton","family":"Chandra Deb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Hove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kodi","family":"Pinks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Njau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5683-2584","authenticated-orcid":true,"given":"Rick J.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"issue":"4","key":"pone.0266047.ref001","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jhep.2013.11.014","article-title":"The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010","volume":"60","author":"I Ditah","year":"2014","journal-title":"J Hepatol"},{"key":"pone.0266047.ref002","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4254\/wjh.v7.i26.2676","article-title":"Hepatitis C virus: A global view","volume":"7","author":"AA Mohamed","year":"2015","journal-title":"World Journal of Hepatology"},{"issue":"SPEC. ISSUE","key":"pone.0266047.ref003","article-title":"The experience of hepatitis C screening among prison inmates with drug injection history","volume":"28","author":"A Kaffashian","year":"2011","journal-title":"J Isfahan Med Sch"},{"issue":"10","key":"pone.0266047.ref004","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/cid\/ciw111","article-title":"Rising mortality associated with Hepatitis C virus in the United States, 2003\u20132013","volume":"62","author":"KN Ly","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0266047.ref005","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/hep.27978","article-title":"Toward a more accurate estimate of the prevalence of hepatitis C in the United States","volume":"62","author":"BR Edlin","year":"2015","journal-title":"Hepatology"},{"key":"pone.0266047.ref006","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2014.301943","article-title":"Epidemiology of hepatitis c virus in pennsylvania state prisons, 2004\u20132012: Limitations of 1945\u20131965 birth cohort screening in correctional settings","volume":"104","author":"S Larney","year":"2014","journal-title":"American Journal of Public Health"},{"issue":"2","key":"pone.0266047.ref007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/430913","article-title":"Hepatitis C Virus Infection among Prisoners in the California State Correctional System","volume":"41","author":"RK Fox","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pone.0266047.ref008","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2105\/AJPH.94.7.1218","article-title":"Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons","volume":"94","author":"GE Macalino","year":"2004","journal-title":"Am J Public Health"},{"issue":"1","key":"pone.0266047.ref009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jurban\/jth085","article-title":"Prevalence of HIV, Syphilis, Hepatitis B, and Hepatitis C among Entrants to Maryland Correctional Facilities","volume":"81","author":"L Solomon","year":"2004","journal-title":"J Urban Heal"},{"key":"pone.0266047.ref010","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/cid\/cis616","article-title":"Hepatitis B and C virus infection among 1.2 million persons with access to care: Factors associated with testing and infection prevalence","volume":"55","author":"PR Spradling","year":"2012","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"pone.0266047.ref011","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis","volume":"58","author":"S Larney","year":"2013","journal-title":"Hepatology"},{"issue":"11","key":"pone.0266047.ref012","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2105\/AJPH.92.11.1789","article-title":"The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997","volume":"92","author":"TM Hammett","year":"2002","journal-title":"Am J Public Health"},{"issue":"RR-1","key":"pone.0266047.ref013","article-title":"Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention","volume":"52","author":"C Weinbaum","year":"2003","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"pone.0266047.ref014","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10096-011-1166-5","article-title":"Hepatitis c and b prevalence in spanish prisons","volume":"30","author":"PS De La Hoya","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"pone.0266047.ref015","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.31541","article-title":"Sero-prevalence of bloodborne tumor viruses (HCV, HBV, HTLV-I and KSHV infections) and related risk factors among prisoners in Razavi Khorasan Province, Iran, in 2008","volume":"16","author":"M Khajedaluee","year":"2016","journal-title":"Hepatitis monthly"},{"issue":"4","key":"pone.0266047.ref016","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/jech.2006.051599","article-title":"Correlates of hepatitis C virus seropositivity in prison inmates: A meta-analysis","volume":"62","author":"MF Vescio","year":"2008","journal-title":"J Epidemiol Community Health"},{"issue":"28","key":"pone.0266047.ref017","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.28.20524","article-title":"Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy","volume":"18","author":"C Semaille","year":"2013","journal-title":"Euro Surveill"},{"issue":"2","key":"pone.0266047.ref018","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1360-0443.2003.00309.x","article-title":"Prison\u2010based syringe exchange programmes: a review of international research and development","volume":"98","author":"K Dolan","year":"2003","journal-title":"Addiction"},{"issue":"3","key":"pone.0266047.ref019","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013\u20102016","volume":"69","author":"MG Hofmeister","year":"2019","journal-title":"Hepatology"},{"key":"pone.0266047.ref020","doi-asserted-by":"crossref","first-page":"103055","DOI":"10.1016\/j.drugpo.2020.103055","article-title":"Babudieri, S. HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C","volume":"90","author":"V Fiore","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"pone.0266047.ref021","article-title":"Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil","volume":"12","author":"MAM Puga","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"pone.0266047.ref022","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijid.2008.06.011","article-title":"Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors","volume":"13","author":"ER Miller","year":"2009","journal-title":"Int J Infect Dis"},{"issue":"2","key":"pone.0266047.ref023","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-132-2-200001180-00003","article-title":"45-year follow-up of hepatitis C virus infection in healthy young adults","volume":"132","author":"LB Seeff","year":"2000","journal-title":"Ann Intern Med"},{"issue":"21","key":"pone.0266047.ref024","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.4254\/wjh.v7.i21.2323","article-title":"Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment","volume":"7","author":"R Zampino","year":"2015","journal-title":"World J Hepatol"},{"issue":"1","key":"pone.0266047.ref025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jiph.2018.08.003","article-title":"Prevalence and sociodemographic disparities of hepatitis C in baby boomers and the US adult population","volume":"12","author":"KJ Moore","year":"2019","journal-title":"Journal of infection and public health"},{"issue":"S3","key":"pone.0266047.ref026","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1002\/hep.510260707","article-title":"Hepatitis C and alcohol","volume":"26","author":"ER Schiff","year":"1997","journal-title":"Hepatology"},{"issue":"5","key":"pone.0266047.ref027","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cgh.2013.06.006","article-title":"Hepatitis B and C in African Americans: current status and continued challenges","volume":"12","author":"KA Forde","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"SUPPL. 4","key":"pone.0266047.ref028","article-title":"Impact of race\/ethnicity and gender on HCV screening and prevalence among US veterans in department of veterans affairs care","volume":"104","author":"LI Backus","year":"2014","journal-title":"Am J Public Health"},{"key":"pone.0266047.ref029","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-018-0231-0","article-title":"Prevalence of hepatitis C virus infection among prisoners in Iran: A systematic review and meta-analysis","volume":"15","author":"M Behzadifar","year":"2018","journal-title":"Harm Reduction Journal"},{"issue":"2","key":"pone.0266047.ref030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7326\/M15-0617","article-title":"Prevention of hepatitis C by screening and treatment in U.S. prisons","volume":"164","author":"T He","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"pone.0266047.ref031","doi-asserted-by":"crossref","DOI":"10.1186\/1940-0640-7-3","article-title":"Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors","volume":"7","author":"IA Binswanger","year":"2012","journal-title":"Addict Sci Clin Pract"},{"issue":"6","key":"pone.0266047.ref032","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cld.739","article-title":"PrO: needle exchange Programs should Be instituted to reduce Hepatitis C virus Transmission","volume":"12","author":"TG Cotter","year":"2018","journal-title":"Clin liver Dis"},{"key":"pone.0266047.ref033","unstructured":"North American Syringe Exchange Network (NASEN) [cited 2021 January 29]. Available from: https:\/\/www.nasen.org\/map\/?go=process."},{"key":"pone.0266047.ref034","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugpo.2018.04.003","article-title":"Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: a systematic review","volume":"57","author":"N Kronfli","year":"2018","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"pone.0266047.ref035","doi-asserted-by":"crossref","first-page":"e0245896","DOI":"10.1371\/journal.pone.0245896","article-title":"Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis","volume":"16","author":"JA Kwon","year":"2021","journal-title":"Plos one"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:39:15Z","timestamp":1648575555000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266047"}},"subtitle":[],"editor":[{"given":"Jee-Fu","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0266047","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,29]]}}}